World Vaccine Congress Asia 2012 - list of speakers

Labeeb M. Abboud is Senior Vice President and General Counsel of the International AIDS Vaccine Initiative, a non-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. IAVI’s activities include research and development, advocacy and public policy. IAVI...

Dr. Akbar, a medical graduate from Bangladesh, received PhD on Hepatology and Immunology from Ehime University Graduate School of Medicine, Ehime, Japan in 1993. His main research activities are focused on elucidating mechanisms underlying genesis of chronic infections and cancers. For the last 2 decades, he has been working on development of...

Dr. Mahtab graduated in Medical Science from Mymensingh Medical College, Bangladesh in 1995. He received MSc in Gastroenterology from Barts & The London Queen Mary’s School of Medicine & Dentistry, University of London, UK in 1998 and subsequently received MD in Hepatology from Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh in...

Patrick Bergstedt was appointed President, Asia Pacific for MSD in September 2011, based in Singapore. He has a proven commercial track record in pharmaceuticals, medical devices, and biologics. His working career spans a number of geographies including South Africa, France, Belgium, and the US. Eighteen years of his career were spent at Hoechst...

Kim Bush is the Deputy Director, Industry Partnerships for the Bill and Melinda Gates Foundation and is based in Seattle, Washington. The Foundation is guided by the belief that every life has equal value. Promoting active engagement with industry is essential for achieving high impact global health outcomes than can help enable all...

Previous Medical Positions 1996~2000 Chairman, Faculty of Medicine, Tzu-Chi University 1993~1996 Research Urologist, UCL Middlesex Hospital, London 1992~2000 Associate Professor in Urology 1989~1991 Chairman, Department of Urology, Tzu-Chi General Hospital 1988~2000 Affiliated Attending urologist, Department of Urology, National Taiwan University...

Dr. Chong had spent 15 years at Sanofi Pasteur in human vaccine research and development. During his tenure there, Dr. Chong had developed two human vaccines, ProHibit against H. influenzae type b and the component pertussis vaccine, and also took a synthetic peptide-based HIV vaccine to phase I clinical trials in 1994. In UBI, Dr. Chong developed ...

Prof. Cutting is the leading authority on the use of Bacillus spores as vaccine vehicles. His work is currently focused on Clostridium difficile, Influenza and TB. He has published numerous papers in internationally peer reviewed journals relating to the use of Bacillus spores as vaccine vehicles and as mucosal adjuvants and is co-inventor on the...

Gerardo obtained a Master degree on Chemistry at Odessa University in the former Soviet Union on 1986, and Ph.D. on Biology at Havana University on 1995. He joined the CIGB in 1986. He has published more than 90 papers and 40 patent applications on hepatitis B, dengue, meningitis, pertussis, HIV, combine vaccines and cancer vaccine developments. ...

Hideki Hasegawa, Director, Department of Pathology, at National Institute of Infectious Diseases (NIID), graduated from the Hokkaido University school of medicine in 1993 with M.D. and finished graduate school at Hokkaido University in 1997 with PhD. He studied at the Rockefeller University and Univeristy College Dublin as an postdoctoral...

Dr. Rod Hoff is the Executive Director of the REDI Centre in Singapore, which is jointly supported by the Ministry of Health of Singapore and the Department of Health and Human Services of the United States. The Centre has a mission to enhance the capability and capacity to monitor, detect and respond to emerging disease threats in the Asian...

Prof. Ken Ishii is currently a Project leader at the Laboratory of Adjuvant Innovation at the National Institute for Biomedical Innovation (NIBIO) as well as a Professor at the Laboratory of Vaccine Science at the Immunology Frontier Research Center (IFREC) of Osaka University in Japan. Prof. Ishii is also honoured to be an Advisor to the Ministry ...

Dr Quazi Monirul Islam, is the Director of the Department of Family Health and Research, World Health Organization, South East Asia Regional Office, New Delhi, India. Dr Islam is a public health specialist qualified from Dhaka University, Bangladesh and received MPH from Amsterdam University and the Royal Tropical Institute in the...

Dr.Suresh Jadhav, M.Pharm., Ph.D. is the Executive Director of Serum Institute of India Ltd., one of the largest vaccine manufacturers from the developing countries, supplying vaccines to more than 140 countries through U.N. Agencies at affordable prices. Dr. Jadhav also led the project of development and introduction of Meningococcal A Conjugate ...

Prof. Rajiv Khanna obtained his doctorate degree from India and undertook his post-doctoral training at the Queensland Institute of Medical Research (QIMR), Brisbane Australia. He is currently appointed as the Director of the Australian Centre for Vaccine Development at QIMR and also holds Senior Principal Research Fellowship from the National...

Patchara KOOTIRATRAKARN, Head Pharmacist, Director of Department of Regulatory Affairs, Pharmacovigilance and Business Operations at GPO-MBP Co., Ltd., graduated from Mahidol University, Bachelor degree of Pharmacy in 1978 and Master degree of Business from Kasetsart University in 1995. She is a qualified person who responsible for the final...

EDUCATION • Medical Doctor (dr); 1981 Atma Jaya University, Jakarta, Indonesia • Master of Science (M.Sc), Majoring Epidemiologi; 1993 University of Indonesia, Depok, Indonesia • Doctoral, Majoring Medicine and Health; 2009 - present Gadjah Mada University; Jogjakarta, Indonesia EMPLOYMENT HISTORY • Head of Health Services Mangga Dua...

Dr. Kapil Maithal is Director-Program Management at International AIDS Vaccine Initiative, a non-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. IAVI’s activities include research and development, advocacy and public policy. IAVI is headquartered...

Dr Nata Menabde has a solid public health academic background and 28 years of experience as a health professional, during which she has built an extensive track record in public health and health systems at country and international levels. As a leader, she has proven her ability to instil a clear vision, effective teamwork and high performance in ...

Professor John Nicholls is a Clinical Professor in Pathology at the University of Hong Kong. He commenced medical studies at the University of Adelaide, South Australia in 1977 and graduated in 1983. He commenced postgraduate training in pathology at the Institute of Medical and Veterinary Sciences, the Queen Elizabeth Hospital and The Adelaide...

Mr. Ors has more than ten years of experience in Licensing, Intellectual Property and business development in biotechnology. He joined Medicago in 2001 and oversees Business Development activities. He is also responsible for securing Medicago's Freedom to Operate and establishing IP strategies. Before joining Medicago, he was licensing manager for ...

Barb was most recently the CTO of Picarro, a company she founded in 1998. At Picarro, she was responsible for technology, research, and business development, which led to a solid-state Cyan laser product in 2003 and cavity ring-down spectroscopy products in 2004. Barb is currently a partner at Skymoon Ventures. Barb received both her Ph.D. (1998)...

Dr. Pan earned his Ph.D in Molecular Virology at National Institute of Diagnostics and Vaccine Development in Infectious Diseases (NIDVD), Xiamen University in 2009. He joined the R&D team of Hepatitis E vaccine and HPV vaccine when he was a Ph. D candidate.Then, Dr. Pan joined Innovax as R&D Dept. Manager in 2009, and take charge of development...

Dr.G.S.Reddy is the Chief General Manager of Indian Immunologicals Limited, a major human and veterinary vaccines manufacturer in India. He obtained basic degree in Veterinary medicine in 1981 from Andhra Pradesh Agricultural University, Hyderabad. He has 28 years of experience in industry, developing veterinary and human...

Shin Sasaki is Director of Vaccine Therapeutic Area, Medical Affairs Department of Pfizer Japan Specialty Care Business Unit, Tokyo, Japan. He has joined Pfizer in 2006 and expanded his role in Medical Affairs as well as Clinical Research Group in infectious diseases and vaccine therapeutic area. He led numerous programs successfully in the area...

July 2011-present Chief Scientific Officer, Wuhan Institute of Biological Products (WIBP), P. R. China. Working on research and development of viral vaccines and diagnostic reagents. May 2003-June 2011 Research Assistant Professor, Institute of Molecular and Cell Biology (IMCB), Singapore Have being working on avian influenza A H5N1...

Timo has 16 years professional experience in the pharmaceutical & chemical industry at Johnson & Johnson and Altana Pharma. He is currently Director Projects Global Technical Services and has worked in local and global technical services as well as in operations. Currently Timo is responsible for the business case and execution of worldwide...

Over twenty years’ working in the field of public health, Dr. Sin Somuny has been a researcher, a publisher, Health System Strengthening Manager, Director, Chairman of a CSO Think Tank on HSS in Cambodia, Deputy Chair for the Public Private Partnership Technical Working Group for Health of the Ministry of Health, and the Chairman of Board of...

BUSINESS EXPERIENCES: April 2010 – Manager, Vaccine Business Planning Department, DaiichiSannkyo, Co. - Management of vaccine research and development ACADEMIC/CLINICAL EXPERIENCES: April 2010 – Visiting Professor of Medical Sciences (Microbiology and Molecular Biodefense Research), Yokohama City University, Yokohama - Basic research on vaccine...

Dr. Jan ter Meulen joined Merck Research Laboratories in 2008 and is responsible for the leadership of all laboratory research on vaccine discovery programs. From 2003 to 2007 he held various positions at Crucell Holland bv, where he pursued the discovery and development of novel vaccines and human monoclonal antibodies against several infectious...

Dr. I-Teh Tong is the Director of Vaccines & Biologics Business Operations at Merck & Co., Inc. He joined Merck in 1992 after receiving his Ph.D. in Chemical Engineering from the University of Wisconsin. He has 20 years experience in vaccine and bioprocess-based API manufacturing, process improvement, process startup, technology...

Dr. Shakti Upadhyay’s experience spans more than 30 years of research in diverse fields such as cell biology, reproductive biology, endocrinology, embryology and immunopharmacology. He holds Ph.D. from University of Paris, France (1977). He worked at the University of California UCLA medical Center, Los Angeles, USA, as Research Associate and...

With nearly 20 years of experience in the healthcare industry, Michel Vounatsos brings to MSD China the vast knowledge and expertise we need to drive us to new levels of success. Mr. Vounatsos has had extensive business experience across the world, in both mature and emerging markets, including Europe (France, Belgium, Poland), the U.S., the...

Dr. Der-Yuan Wang has been working in the field of vaccines, blood products, in vitro diagnostics and cell-based products over fifteen years. Prior to joining the Taiwan Food and Drug Administration (Taiwan FDA) in Jan 2010, he worked at the Bureau of Food and Drug Analysis, Department of Health of Taiwanese Government for twelve years. Dr. Wang ...

Bing Yan, MD, MBA is currently Head of Clinical Development Asia & China Vaccines Lead, Emerging Markets at Pfizer Inc. In his role, Dr. Yan is responsible for clinical research strategy and implementation in Asia across a broad range of therapeutic areas, with a primary focus in China. In addition, he is on special assignment to lead the vaccines ...